Nephrocare Health Services Limited submitted a clarification to its previous disclosure dated May 26, 2026 regarding the incorporation of NPHSK LLP in the Republic of Kazakhstan. The clarification corrects the subsidiary status description that was inadvertently misstated in the original disclosure.

Key Correction

NPHSK LLP was incorrectly referred to as a step-down wholly owned subsidiary in the May 26, 2026 disclosure. The company clarifies that:

  • Nephrocare Health Services International Pte. Ltd. ("NHSI"), Singapore (a wholly owned subsidiary of the Company) holds 99% of the charter capital of NPHSK LLP
  • The balance 1% is held by another participant
  • Accordingly, NPHSK LLP is a step-down subsidiary (not wholly owned) of the Company

Subsidiary Details (Annexure A)

Entity Information:

  • Name: NPHSK LLP
  • Date of Incorporation: May 26, 2026
  • Country of Incorporation: Republic of Kazakhstan
  • Incorporated by: Nephrocare Health Services International Pte. Ltd., Singapore (overseas wholly-owned subsidiary of the Company)

Ownership Structure:

  • Immediate holding company: Nephrocare Health Services International Pte. Ltd. (Singapore Registration No. 201904925M)
  • Relationship: Overseas wholly-owned subsidiary of Nephrocare Health Services Limited
  • Status: Step-down overseas subsidiary of the Company

Business Operations:

  • Industry: Healthcare and Management Services
  • Business Objective: Undertaking holding and management activities to expand kidney care and dialysis services network in Kazakhstan
  • Activities: Establishment and operation of dialysis centres, procurement of medical equipment and consumables, provision of comprehensive patient care and related healthcare services

Regulatory Approvals:

  • Incorporated in accordance with Laws of the Republic of Kazakhstan
  • No additional special governmental or regulatory approvals required beyond standard registration under Kazakhstani law
  • Specific regulatory/licensing approvals will be obtained as required for regulated activities

Financial Details:

  • Nature of consideration: Cash consideration
  • Charter capital: KZT 5,000,000 (Kazakhstani Tenge Five Million)
  • Total subscription cost: KZT 5,000,000 (approximately USD 10,500 at applicable exchange rate)
  • Shareholding: NHSI holds 99% of charter capital, another participant holds 1%

Impact Statement

All other information contained in the earlier disclosure dated May 26, 2026 remains unchanged. This clarification only corrects the description of the subsidiary ownership structure.

Availability

The disclosure is available on the company website at www.nephroplus.com